Goal: We describe the relationship between mean arterial pressure (MAP) and glomerular filtration rate (GFR) since therapies affecting MAP can have large effects on kidney function. Methods: We developed a closed-loop, steady-state mechanistic model of the human kidney with a reduced parameter set estimated from measurements. Results: The model was first validated against literature models. Further, GFR was validated against intensive care patient data (root mean squared error (RMSE) 13.5 mL/min) and against hypertensive patients receiving sodium nitroprusside (SNP) (RMSE less than 5 mL/min). A sensitivity analysis of the model reinforced the fact that vascular resistance is inversely related to GFR and showed that changes to either vascular resistance or renal autoregulation cause a significant change in sodium concentration in the descending limb of Henle. Conclusions: This model can be used to determine the impact of MAP on GFR and overall kidney health. The modeling framework lends itself to personalization of the model to a specific human.
Goal: We describe the relationship between mean arterial pressure (MAP) and glomerular filtration rate (GFR) since therapies affecting MAP can have large effects on kidney function. Methods: We developed a closed-loop, steady-state mechanistic model of the human kidney with a reduced parameter set estimated from measurements. Results: The model was first validated against literature models. Further, GFR was validated against intensive care patient data (root mean squared error (RMSE) 13.5 mL/min) and against hypertensive patients receiving sodium nitroprusside (SNP) (RMSE less than 5 mL/min). A sensitivity analysis of the model reinforced the fact that vascular resistance is inversely related to GFR and showed that changes to either vascular resistance or renal autoregulation cause a significant change in sodium concentration in the descending limb of Henle. Conclusions: This model can be used to determine the impact of MAP on GFR and overall kidney health. The modeling framework lends itself to personalization of the model to a specific human.
Authors: Victor G Puelles; Wendy E Hoy; Michael D Hughson; Boucar Diouf; Rebecca N Douglas-Denton; John F Bertram Journal: Curr Opin Nephrol Hypertens Date: 2011-01 Impact factor: 2.894
Authors: Aleksandar Denic; John C Lieske; Harini A Chakkera; Emilio D Poggio; Mariam P Alexander; Prince Singh; Walter K Kremers; Lilach O Lerman; Andrew D Rule Journal: J Am Soc Nephrol Date: 2016-07-08 Impact factor: 10.121
Authors: Jacobien C Verhave; Pierre Fesler; Guilhem du Cailar; Jean Ribstein; Michel E Safar; Albert Mimran Journal: Hypertension Date: 2005-02-28 Impact factor: 10.190
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente Journal: Ann Intern Med Date: 2006-08-15 Impact factor: 25.391
Authors: Michael E Hall; Jussara M do Carmo; Alexandre A da Silva; Luis A Juncos; Zhen Wang; John E Hall Journal: Int J Nephrol Renovasc Dis Date: 2014-02-18
Authors: Alistair E W Johnson; Tom J Pollard; Lu Shen; Li-Wei H Lehman; Mengling Feng; Mohammad Ghassemi; Benjamin Moody; Peter Szolovits; Leo Anthony Celi; Roger G Mark Journal: Sci Data Date: 2016-05-24 Impact factor: 6.444